BioNTech SE (BNTX) September call option implied volatility flat
Tweet
Share
E-mail
Get Alerts BNTX Hot Sheet
Join SI Premium – FREE
BioNTech SE (NASDAQ: BNTX) September call option implied volatility is at 44, October is at 37; compared to its 52-week range of 30 to 71 after FDA announces approval for 2023-2024 COVID-19 vaccine.
Create E-mail Alert Related Categories
OptionsRelated Entities
Options, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
